Back to Search
Start Over
Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy
- Source :
- Clinical & Experimental Immunology, PubMed Central
- Publication Year :
- 2017
- Publisher :
- Oxford University Press (OUP), 2017.
-
Abstract
- The goal of this study was to investigate the glycosylation profile of native immunoglobulin (Ig)G present in serum immune complexes in patients with rheumatoid arthritis (RA). To accomplish this, lectin binding assays, detecting the accessibility of glycans present on IgG-containing immune complexes by biotinylated lectins, were employed. Lectins capturing fucosyl residues (AAL), fucosylated tri-mannose N-glycan core sites (LCA), terminal sialic acid residues (SNA) and O-glycosidically linked galactose/N-acetylgalactosamine (GalNac-L) were used. Patients with recent-onset RA at baseline and after 3-year follow-up were investigated. We found that native IgG was complexed significantly more often with IgM, C1q, C3c and C-reactive protein (CRP) in RA patients, suggesting alterations of the native structure of IgG. The total accessibility of fucose residues on captured immune complexes to the respective lectin was significantly higher in patients with RA. Moreover, fucose accessibility on IgG-containing immune complexes correlated positively with the levels of antibodies to cyclic citrullinated peptides (anti-CCP). We also observed a significantly higher accessibility to sialic acid residues and galactose/GalNAc glyco-epitopes in native complexed IgG of patients with RA at baseline. While sialic acid accessibility increased during treatment, the accessibility of galactose/GalNAc decreased. Hence, successful treatment of RA was associated with an increase in the SNA/GalNAc-L ratio. Interestingly, the SNA/GalNAc-L ratio in particular rises after glucocorticoid treatment. In summary, this study shows the exposure of glycans in native complexed IgG of patients with early RA, revealing particular glycosylation patterns and its changes following pharmaceutical treatment. Funding Agencies|Volkswagen-foundation; Thyssen-Stiftung; German Research Foundation (DFG) [CRC1181-C03, KFO257, GK1660]; EU [690836]; County Council of ostergotland; Swedish Society for Medical Research; Swedish Rheumatism Association; Swedish Society of Medicine; Professor Nanna Svartz Foundation; Svenska Sallskapet for Medicinsk Forskning; Svenska Lakaresallskapet; King Gustaf V 80-year Foundation
- Subjects :
- Adult
Male
0301 basic medicine
Glycan
Glycosylation
Immunology
Antigen-Antibody Complex
Fucose
Immunoglobulin G
Arthritis, Rheumatoid
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Polysaccharides
Sambucus nigra
Lectins
Humans
Immunology and Allergy
Dermatologi och venereologi
Aleura aurantia
GalNAc-L
immune complex
lectin ELISA
rheumatoid arthritis
Aged
030203 arthritis & rheumatology
biology
Complement C1q
Galactose
Lectin
Original Articles
Middle Aged
Immune complex
Immunoglobulin A
3. Good health
Sialic acid
Dermatology and Venereal Diseases
carbohydrates (lipids)
C-Reactive Protein
030104 developmental biology
Immunoglobulin M
chemistry
Biochemistry
Complement C3c
Sialic Acids
biology.protein
Female
Antibody
Subjects
Details
- ISSN :
- 13652249 and 00099104
- Volume :
- 189
- Database :
- OpenAIRE
- Journal :
- Clinical and Experimental Immunology
- Accession number :
- edsair.doi.dedup.....7e9c9d620332d1bbd46ad12a6477a666
- Full Text :
- https://doi.org/10.1111/cei.12987